Joe Mara | Vice President, Investor Relations |
Michel Vounatsos | Chief Executive Officer |
Alfred Sandrock, Jr. | Executive Vice President, Research & Development and Chief Medical Officer |
Jeffrey Capello | Executive Vice President and Chief Financial Officer |
Marc Goodman | SVB Leerink |
Terence Flynn | Goldman Sachs |
Umer Raffat | Evercore ISI |
Ronny Gal | Bernstein |
Phil Nadeau | Cowen and Company |
Michael Yee | Jefferies |
Jay Olson | Oppenheimer |
Evan Seigerman | Credit Suisse |
Cory Kasimov | JPMorgan |
Matthew Harrison | Morgan Stanley |
Carter Gould | Barclays |
Good morning. My name is Lisa, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter 2020 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session.